Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Single Ascending Dose Safety and Tolerability Clinical Trial of PST-611 in Subjects With Dry Age-related Macular Degeneration

NCT07024732 is registered in ClinicalTrials.gov with Eyevensys as lead sponsor.

NCT NCT07024732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07024732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Single Ascending Dose Safety and Tolerability Clinical Trial of PST-611 in Subjects With Dry Age-related Macular Degeneration
Lead sponsor
Eyevensys
Phase
Phase 1
Overall status
Completed
Start date
June 23, 2025
Completion date
April 7, 2026
Enrollment
8 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dry age related macular degeneration